Literature DB >> 30600936

Ustekinumab Fails to Show Efficacy in a Phase III Axial Spondyloarthritis Program: The Importance of Negative Results.

Philip Mease1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30600936     DOI： 10.1002/art.40759

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN： 2326-5191            Impact factor:   10.995


× No keyword cloud information.
  12 in total

Review 1.  Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis.

Authors:  Philip Mease
Journal:  Curr Rheumatol Rep       Date:  2019-06-06       Impact factor: 4.592

Review 2.  IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases.

Authors:  Hao Li; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2020-11-13       Impact factor: 8.667

Review 3.  Targeting inflammatory pathways in axial spondyloarthritis.

Authors:  Daniel E Furst; James S Louie
Journal:  Arthritis Res Ther       Date:  2019-06-04       Impact factor: 5.156

Review 4.  Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis.

Authors:  Dennis McGonagle; Abdulla Watad; Kassem Sharif; Charlie Bridgewood
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

Review 5.  Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis.

Authors:  Angela Ceribelli; Francesca Motta; Matteo Vecellio; Natasa Isailovic; Francesco Ciccia; Carlo Selmi
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

Review 6.  Axial Psoriatic Disease: Clinical and Imaging Assessment of an Underdiagnosed Condition.

Authors:  Ivan Giovannini; Alen Zabotti; Carmelo Cicciò; Matteo Salgarello; Lorenzo Cereser; Salvatore De Vita; Ilaria Tinazzi
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

7.  Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.

Authors:  Philip S Helliwell; Dafna D Gladman; Soumya D Chakravarty; Shelly Kafka; Chetan S Karyekar; Yin You; Kim Campbell; Kristen Sweet; Arthur Kavanaugh; Lianne S Gensler
Journal:  RMD Open       Date:  2020-02

Review 8.  Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.

Authors:  Kevin L Winthrop; Michael E Weinblatt; Joan Bathon; Gerd R Burmester; Philip J Mease; Leslie Crofford; Vivian Bykerk; Maxime Dougados; James Todd Rosenbaum; Xavier Mariette; Joachim Sieper; Fritz Melchers; Bruce N Cronstein; Ferry C Breedveld; Joachim Kalden; Josef S Smolen; Daniel Furst
Journal:  Ann Rheum Dis       Date:  2019-10-29       Impact factor: 19.103

9.  Enthesitis in psoriatic arthritis (Part 3): clinical assessment and management.

Authors:  Philip Mease
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580

Review 10.  Similarities and Differences Between Juvenile and Adult Spondyloarthropathies.

Authors:  Corinne Fisher; Coziana Ciurtin; Maria Leandro; Debajit Sen; Lucy R Wedderburn
Journal:  Front Med (Lausanne)       Date:  2021-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.